BTTX insider transaction filings
Better Therapeutics, Inc. — 12 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-02-13. Screen BTTX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for BTTX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Better Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-13 | 4 | PERRY DAVID P — Executive Chairman, Director, 10% owner David P. Perry 2015 Trust — 10% owner | Grant/award (A): 839,895 @ $0.19 | EDGAR |
| 2024-01-10 | 4 | PERRY DAVID P — Executive Chairman, Director, 10% owner | Grant/award (A): 1,471,453 @ $0.17 | EDGAR |
| 2023-12-20 | 4 | Wynholds Kristin — Chief Product Officer | Grant/award (A): 25,362 @ $0 | EDGAR |
| 2023-12-20 | 4 | Miller Leslie A. — Principal Accounting Officer | Grant/award (A): 3,587 @ $0 | EDGAR |
| 2023-12-20 | 4 | Berman Mark A. — Chief Medical Officer | Grant/award (A): 25,362 @ $0 | EDGAR |
| 2023-12-20 | 4 | Armanino Andrew J. — Director | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2023-12-20 | 4 | Granger Elder — Director | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2023-12-20 | 4 | Parker Geoffrey M. — Director | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2023-12-20 | 4 | Carmona Richard H — Director | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2023-12-20 | 4 | KARBE FRANK — Chief Executive Officer, Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2023-12-20 | 4 | PERRY DAVID P — Executive Chairman, Director, 10% owner | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2023-12-20 | 4 | LAVIZZO-MOUREY RISA J — Director | Grant/award (A): 3,750 @ $0 | EDGAR |
Recent 8-K events — Better Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-21 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2024-03-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-03-14 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BTTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →